<DOC>
	<DOCNO>NCT01486732</DOCNO>
	<brief_summary>This randomize placebo-controlled trial recognize new cell regeneration brain use FLT-PET .</brief_summary>
	<brief_title>FLT-PET Activity Change After Allogeneic Umbilical Cord Blood ( UCB ) Therapy Cerebral Palsy</brief_title>
	<detailed_description>FLT ( 3'-Deoxy-3'- [ F-18 ] Fluorothymidine ) develop cell-proliferation tracer . In animal study , FLT-PET use tool enables image measure proliferation brain , thus detect activity endogenous neural stem cell noninvasively . This study aim assess cell proliferation activity change brain Umbilical Cord Blood ( UCB ) Therapy Cerebral Palsy patient use FLT-PET .</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<criteria>Cerebral Palsy Abnormal muscle tone Gross Motor Function Classification System ( GMFCS ) : I , II , III , IV , V Willing comply study procedure Medical instability include pneumonia renal function enrollment Presence know genetic disease Presence drug hypersensitivity relate study remedy Poor cooperation guardian , include inactive attitude rehabilitation visit followup Decision principal investigator unexpected event include brain surgery , may affect outcome</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Cerebral Palsy</keyword>
	<keyword>Umbilical Cord Blood</keyword>
	<keyword>FLT-PET</keyword>
</DOC>